TCDA

Tricida Inc.

Price

return (12m)

p/e

-0.01

p/bv

-0.01

DIVIDEND YIELD

0.00%

TCDA price

Tricida

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment TCDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals TCDA

Valuation

P/E

-0.01

Sector 1.09

Industry -1.78

P/BV

-0.01

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.55

Industry 2.25

EV/EBITDA

-4.87

Sector -47.62

Industry -42.38

EV/EBIT

-4.86

Sector -27.52

Industry -45.58

P/EBITDA

-0.01

Sector -32.64

Industry -23.10

P/EBIT

-0.01

Sector -43.02

Industry -27.18

P/Total Assets

0.01

Sector 0.87

Industry 0.82

P/Net Current Assets

Sector -27.09

Industry -72.46

P/Working Capital

Sector -4.05

Industry -2.10

EPS

-2.31

Sector -0.70

Industry -1.11

BVPS

-2.35

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

0.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

0.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

0.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

98.39%

Sector -24.32%

Industry -33.33%

ROA

-142.64%

Sector -24.41%

Industry -45.72%

ROIC

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.90

Industry 2.51

Net Debt / EBITDA

-4.84

Sector -4.96

Industry -8.98

Net Debt / EBIT

-4.83

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.85

Sector -0.45

Industry -1.16

Gross Debt / Equity

-1.44

Sector -0.74

Industry -0.56

Equity/Assets

-1.45

Sector 0.46

Industry 0.52

Liabilities/Assets

-1.45

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-5.38%

Sector -

Industry -

Fundamentals TCDA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
TCDA Tricida Inc.	$0.00	-	0.00%	-0.01	-0.01	98.39%	0.00%
LLY Eli Lilly and Compay	$1,142.35	51.23%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.38	-6.23%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.03	29.66%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.69	-30.85%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.73	-12.06%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-17.58%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.78	-95.06%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$139.78	16.35%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$653.75	38.92%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$429.56	8.26%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.66	9.40%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

TCDA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Tricida

Tricida Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2018

Time since IPO - 8 years

64

Employees

Tricida Inc. (United States) is listed on the Nasdaq and has a market capitalization of $754.21 Thousand, with shareholders equity totaling $-136.10 million.

The company employs approximately 64 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Tricida Inc. reported $- in revenue, generating net income of $-133.91 million.

Key financial metrics include a P/E ratio of -0.01, a price-to-book (P/B) ratio of -0.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TCDA.

Market cap

$754.21 Thousand

Net worth

$-136.10 million

$-136,098,000.00

Assets

$93.88 million

$93,879,000.00

Total Shares Outstanding

58.02 million

58,015,000

Average Daily Trading Volume

$4.61 million

$4,613,911.42

Sector

Health

Industry

Pharmaceutical Products

TCDA

TCDA revenue and profits

Financial Results TCDA

DRAG THE FRAME TO SEE MORE DATA

TCDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35